Abstract
Purpose/Objective: For the treatment of early-stage Hodgkin disease (HD), both the American College of Radiology Appropriateness Criteria Index and the National Comprehensive Cancer Network Practice Guidelines rate combined modality therapy (CMT) the most appropriate treatment approach, while giving chemotherapy (CT) alone the lowest consensus score. However, even in the presence of these guidelines, considerable heterogeneity exists in the treatment for early-stage HD. In this study, we sought to determine the concordance of treatment recommendations by practicing oncologists for early-stage HD with the existing guidelines and to analyze the variation in practice patterns among physicians. We also explored factors that influence a physician’s thought process and bias in rendering a treatment recommendation for this patient population.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
